相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Heat-Shock Protein 90 Improves Efficacy of Rapamycin in a Model of Hepatocellular Carcinoma in Mice
Sven A. Lang et al.
HEPATOLOGY (2009)
mTOR, cancer and transplantation
Edward K. Geissler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Liver transplantation for hepatocellular carcinoma
Julie K. Heimbach
CANCER JOURNAL (2008)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
Michael A. Zimmerman et al.
LIVER TRANSPLANTATION (2008)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: Long-term outcomes and side effects
Christian Toso et al.
TRANSPLANTATION (2007)
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
Josep M. Campistol et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
HM Kauffman et al.
TRANSPLANTATION (2005)
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
NM Kneteman et al.
LIVER TRANSPLANTATION (2004)
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice
GE Koehl et al.
TRANSPLANTATION (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth
G Schumacher et al.
TRANSPLANTATION PROCEEDINGS (2002)
Rapamycin blocks tumor progression: Unlinking immunosuppression from antitumor efficacy
FL Luan et al.
TRANSPLANTATION (2002)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients
M Herman et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
分享论文
